White Paper

Aggregation In Pharma: The Future-Proof Solution

Source: Wipotec
Aggregation In Pharma: The Future-Proof Solution

Aggregation in the pharmaceutical industry: the technological leap and its advantages.

Aggregation stands for a technology leap in the healthcare supply chain that can take a dimension similar to a blockchain in the financial industry. The white paper highlights, in the form of numerous facts on worldwide regulatory requirements for aggregation, the fact that there are no limits to progress in the pharmaceutical industry. It explains in detail how drug manufacturers can trace the origin of their product completely according to the "parent-child principle". At the same time, the white paper provides an insight into the improvement potential of all processes along the supply chain using aggregation. The focus is not only on the start and end points, but also on useful additional information on the correct handling of delivery damages of aggregated medicine consignments.

The white paper addresses legal peculiarities of individual states such as Russia or India. The combination of important facts and a multitude of valuable information helps to keep the essential overview in these dynamic times.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online